chr17-80086090-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017950.4(CCDC40):​c.2323G>A​(p.Val775Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0862 in 1,614,060 control chromosomes in the GnomAD database, including 7,071 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V775V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.11 ( 1255 hom., cov: 32)
Exomes 𝑓: 0.083 ( 5816 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.64

Publications

13 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017687082).
BP6
Variant 17-80086090-G-A is Benign according to our data. Variant chr17-80086090-G-A is described in ClinVar as Benign. ClinVar VariationId is 162851.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC40NM_017950.4 linkc.2323G>A p.Val775Met missense_variant Exon 14 of 20 ENST00000397545.9 NP_060420.2 Q4G0X9-1
CCDC40NM_001243342.2 linkc.2323G>A p.Val775Met missense_variant Exon 14 of 18 NP_001230271.1 Q4G0X9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkc.2323G>A p.Val775Met missense_variant Exon 14 of 20 5 NM_017950.4 ENSP00000380679.4 Q4G0X9-1
CCDC40ENST00000574799.5 linkn.1860G>A non_coding_transcript_exon_variant Exon 10 of 16 1
CCDC40ENST00000374877.7 linkc.2323G>A p.Val775Met missense_variant Exon 14 of 18 5 ENSP00000364011.3 Q4G0X9-2
CCDC40ENST00000572253.5 linkn.950G>A non_coding_transcript_exon_variant Exon 3 of 6 2

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
17475
AN:
152128
Hom.:
1251
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0645
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.0824
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.166
Gnomad NFE
AF:
0.0819
Gnomad OTH
AF:
0.112
GnomAD2 exomes
AF:
0.0880
AC:
21937
AN:
249388
AF XY:
0.0886
show subpopulations
Gnomad AFR exome
AF:
0.211
Gnomad AMR exome
AF:
0.0525
Gnomad ASJ exome
AF:
0.106
Gnomad EAS exome
AF:
0.000612
Gnomad FIN exome
AF:
0.111
Gnomad NFE exome
AF:
0.0855
Gnomad OTH exome
AF:
0.0949
GnomAD4 exome
AF:
0.0832
AC:
121580
AN:
1461812
Hom.:
5816
Cov.:
32
AF XY:
0.0839
AC XY:
61034
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.217
AC:
7252
AN:
33476
American (AMR)
AF:
0.0559
AC:
2498
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2748
AN:
26136
East Asian (EAS)
AF:
0.000378
AC:
15
AN:
39700
South Asian (SAS)
AF:
0.0990
AC:
8543
AN:
86252
European-Finnish (FIN)
AF:
0.114
AC:
6062
AN:
53406
Middle Eastern (MID)
AF:
0.128
AC:
736
AN:
5744
European-Non Finnish (NFE)
AF:
0.0795
AC:
88388
AN:
1111986
Other (OTH)
AF:
0.0884
AC:
5338
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
6928
13856
20783
27711
34639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3252
6504
9756
13008
16260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.115
AC:
17488
AN:
152248
Hom.:
1255
Cov.:
32
AF XY:
0.114
AC XY:
8523
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.207
AC:
8603
AN:
41540
American (AMR)
AF:
0.0643
AC:
985
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
361
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5170
South Asian (SAS)
AF:
0.0825
AC:
398
AN:
4824
European-Finnish (FIN)
AF:
0.115
AC:
1215
AN:
10600
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.0819
AC:
5573
AN:
68014
Other (OTH)
AF:
0.111
AC:
234
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
791
1582
2373
3164
3955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0909
Hom.:
1679
Bravo
AF:
0.115
TwinsUK
AF:
0.0771
AC:
286
ALSPAC
AF:
0.0815
AC:
314
ESP6500AA
AF:
0.185
AC:
775
ESP6500EA
AF:
0.0846
AC:
711
ExAC
AF:
0.0915
AC:
11069
Asia WGS
AF:
0.0530
AC:
186
AN:
3478
EpiCase
AF:
0.0858
EpiControl
AF:
0.0860

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val775Met in exon 14 of CCDC40: This variant is not expected to have clinical si gnificance because it has been identified in 18.5% (775/4194) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs60684213). -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 27, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia 15 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.049
.;T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.50
N
LIST_S2
Benign
0.69
T;T
MetaRNN
Benign
0.0018
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L;L
PhyloP100
1.6
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.74
N;N
REVEL
Benign
0.035
Sift
Benign
0.15
T;T
Sift4G
Benign
0.12
T;T
Polyphen
0.19
.;B
Vest4
0.080
MPC
0.21
ClinPred
0.0066
T
GERP RS
2.7
Varity_R
0.027
gMVP
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60684213; hg19: chr17-78059889; COSMIC: COSV107494471; API